You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Mitul Kotecha, Head of Global FX Strategy at Credit Agricole, says euro-dollar could reach 1.20 in the medium-term, but maintains a 1.25-1.2...
Jiong Shao, Chief China Strategist, Macquarie discusses Alibaba Group's decision to buy back a 20 percent stake held by Yahoo for $7.1 billi...
Emerging markets turn negative for the year. Could the U.S. selloff be mirroring the dip in the emerging markets? Tim Seymour, managing part...
A look at the market moving activities across Europe, including continued weakness in Greek banks and Spanish bonds, with CNBC's Simon Hobbs...
Bill McDermott, SAP AG co-CEO, discusses his company's new cloud platform and focus on mobile working tools.
Mark Yockey, Artisan International Fund, shares perspective on where to invest in Europe and what would happen if Greece were to exit the eu...
John Saunders, CEO Asia, MGPA says that there is an oversupply of residential property in China.
Todd Elmer, Currency Strategist, Citi says he doesn't foresee much more downside for the Australian dollar.
Andrew Freris, Chief Investment Advisor for Asia explains why JPMorgan's $2 billion loss is not a big deal.
Jack Bouroudjian, CEO, Bull and Bear Partners discusses what JPMorgan's $2 billion loss means for the bank and investors.
Cisco issued an alarming Q4 sales and profit forecast that fell short of estimates, with Simon Leopold, analyst at Raymond James, and Mark S...
The S&P 500 is bouncing back from session lows, but still down for the day, and concerns over the euro zone continue. Sharing perspective on...
Discussing the problems in Europe and the Federal Reserve's readiness to help, with Jim Iuorio, TJM Institutional Services; Dennis Berman, W...
Posts |
COMPANY : Sanofi-Aventis SA
16 Mar 2012
Take a look at some of Friday morning’s early movers:... Read More
15 Mar 2012
Take a look at some of Thursday morning’s early movers:... Read More
24 Feb 2012
Speculation has its place, but Cramer's researcher thinks there is lots of opportunity to profit from established companies, too.... Read More
27 Jan 2012
Cramer thinks big pharma stocks could soon pop, so here's his preferred plays.... Read More
News |
COMPANY : Sanofi-Aventis SA
Thursday, 5 Apr 2012
Posted By:
| Source: CNBC.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
